Hutch News
Results per Page:
Science Says: The promise of precision medicine
How understanding unique traits of individuals and their cancers can lead to precise treatments
Good and surprising news finds germline mutations are rare in low-risk prostate cancer
From the Nelson Lab, part of the Human Biology and Public Health Sciences Divisions
New study identifies genetic changes in patients who progress to esophageal cancer
Findings in precancerous Barrett’s esophagus a step toward improved screening, prevention
Development of an in vitro model system to study tricky-to-target tumor microenvironment cells
From the Gujral Lab, Human Biology Division
Dr. Denise Galloway elected Fellow of the American Association for Cancer Research Academy
Cancer biologist contributed basic and translational insights that made the cancer-preventive HPV vaccine possible
Transcriptional consequences of oncogenic Fbw7 mutations
From the Clurman Lab, part of the Human Biology and Clinical Research Divisions
Dr. Andrew Hsieh elected member of American Society for Clinical Investigation
Physician-scientist demonstrated central role protein synthesis plays in cancer
Dr. Siqi Li named a 2022 Damon Runyon Fellow
Beronja Lab postdoc will study how interactions between normal and mutated skin stem cells stave off cancer
When more is more: Increased levels of wild-type and mutant RIT1 promote oncogenesis
From the Berger Lab, Human Biology Division
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Viral histone-like protein co-opts host proteins to hijack cell cycle regulation
From the Avgousti Lab, Human Biology Division
Computational predictions reveal an unexpected synergy for prostate cancer therapy
From the Gujral Lab, Human Biology Division
Holland receives NCI Outstanding Investigator Award
Neuroscientist will tackle genetic abnormalities that drive cancers and could be therapeutic targets
Science Says: Cracking the code in solid tumors
How scientists are developing targeted new therapies for cancers of the breast, lung, stomach and more
Liver cancer researcher Dr. Abir Arfaoui named latest Brave Fellow
Running community honors late athlete Gabe Grunewald by funding rare cancer research at Fred Hutch
Building better lab models of human tumors
Dr. John Lee receives $1.5M NIH New Innovator Award for creative young scientists with high-risk, high-reward projects
Using AI to identify potential COVID-19, cancer therapies
Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
Fred Hutch scientist Dr. Trevor Bedford receives MacArthur Fellowship
Recognized for research and public health contributions in tracking viral spread and evolution
Matsen, Bedford named Howard Hughes Medical Institute Investigators
Acclaimed computational biologists each awarded 7 years of funding